Please login to bookmarkClose

A landmark Federal Court class action against private health insurer Medibank will be a test case for when privacy claims can sidestep the regulatory path, and whether group members can prove they suffered loss from exposure of their data.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au